Diethyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate, 95.0%, 500mg

p-Nitrophenyl-�-D-galactoyranoside, 95%, 5g

3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

Methyl 6-nitroindole-3-carboxylate, 98%, 10g

4,6-Diamino-5-nitropyrimidine, 95.0%, 5g

CyPFt-Bu, 98%, 5g

2-(bromomethyl)-4,5-dimethyl-1,3-thiazole hydrobromide, 95.0%, 1g

5,11-Dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl-5-(2,2,2-trifluoroethyl)-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one, 98%, 50mg

1,6,20,25-Tetraaza[6.1.6.1]paracyclophane>98.0%(HPLC)100mg

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Quinoline-5,8-dione, 95.0%, 1g

Ethyl 2-(4-chloro-2-(methylthio)pyrimidin-5-yl)acetate, 95.0%, 10g

2-Fluoroterephthalonitrile, 95.0%, 100mg